TY - JOUR T1 - Adverse drug reactions JF - Clinical Medicine JO - Clin Med SP - 481 LP - 485 DO - 10.7861/clinmedicine.16-5-481 VL - 16 IS - 5 AU - Jamie J Coleman AU - Sarah K Pontefract Y1 - 2016/10/01 UR - http://www.rcpjournals.org/content/16/5/481.abstract N2 - Adverse drug reactions (ADRs) remain a challenge in modern healthcare, particularly given the increasing complexity of therapeutics, an ageing population and rising multimorbidity. This article summarises some of the key facts about ADRs and explores aspects relating to their prevention, diagnosis, reporting and management in current clinical practice. ER -